gradient: 0-1 min 5% B; 1-20 min 5 to 70% B; flow: 0.5 mL/min. Thiofucoside S1 (Thoma et al., 1997) and D-GlcNAc acceptor S2 (Takaku et al., 2006) were coupled under in situ anomerization conditions to give disaccharide S3 (Lemieux et al., 1975) , which upon regioselective opening of the benzylidene acetal (Sherman et al., 2003) yielded acceptor S4 (Scheme S1). SLe x precursor S6 was synthesized via DMTST (Fugedi and Garegg, 1986 ) promoted coupling of S5 (Bhunia et al., 2008) and S4. Hydrogenolytic debenzylation and saponification finally afforded TMSE protected sLe x .
Scheme S1 a) Br 2 , Bu 4 NBr, CH 2 Cl 2 , MS 4 Å, 0 °C to r.t., 12 h, 55%; b) Me 3 N·BH 3 , AlCl 3 , H 2 O, THF, r.t., 5 h, 78%; c) DMTST, CH 2 Cl 2 , MS 4 Å, r.t., 5 d, 20%; d) H 2 , Pd(OH) 2 /C, dioxane, H 2 O, r.t., 24 h; e) aq. NaOH, MeOH, r.t., 20 h, 43% from S5.
2-(Trimethylsilyl)ethyl (2,3,4-tri-O-benzyl-α-L-fucopyranosyl)-(1→3)-2-acetamido-4,6-Obenzylidene-2-deoxy-β-D-glucopyranoside (S3)
. Bromine (0.18 mL, 3.50 mmol) was slowly added to a stirred solution of donor S1 (1.52 g, 3.18 mmol) in anhydrous CH 2 Cl 2 (90 mL) at 0 °C under argon. After 10 min, excess bromine was quenched by addition of cyclohexene. Powdered activated molecular sieves 4 Å (9 g), TBAB (1.54 g, 4.78 mmol) and S2 (Takaku et al., 2006) (0.65 g, 1.59 mmol) were added and the mixture was stirred at 0 °C for 2 h then warmed to r.t.
and stirred overnight. The reaction mixture was filtered through celite and washed with water 138.9, 138.8, 138.7, 129.2, 128.8, 128.5, 128.4, 128.3, 128.0, 127.9, 127.7, 127.5, 126 .4 (24C, Ar-C), 101.8 (CHPh), 100.1 (GlcNAc-C1), 98. 138.6, 138.4, 128.7, 128.6, 128.5, 128.4, 128.1, 128.0, 127.9, 127.8, 127.7, 127.6 (24C, 138.8, 138.6, 134.8, 133.4, 129.8, 129.0, 128.8, 128.6, 128.5, 128.4, 128.3, 127.8, 127.7, 127.6, 127.5, 127.3 
2-(Trimethylsilyl)ethyl (sodium 5-acetamido-3,5-dideoxy-D-glycero-α-D-galacto-2-nonulopyranosynate)-(2→3)-β-D-galactopyranosyl-(1→4)-[α-L-fucopyranosyl-(1→3)]-2-acetamido-2-deoxy-β-D-glucopyranoside (sLe x -OTMSE).
Compound S6 (90 mg, 0.052 mmol)
was dissolved in dioxane/water (4:1, 10 mL) under argon. Pd(OH) 2 /C (20 mg, 10% Pd) was added and the resulting mixture was hydrogenated (4 bar H 2 ) at r.t. After 24 h, the mixture was filtered and the solvent was removed under reduced pressure. The residue was redissolved in 1 N aq NaOH (10 mL) and MeOH (2 mL) and stirred at r.t. After 20 h the mixture was neutralized with 1 N HCl, the volatiles were removed under reduced pressure, and the crude product was purified by size-exclusion chromatography and RP chromatography (RP18, H 2 O/MeOH). 102.6 (Gal-C1), 101.2, 100.6 (GlcNAc-C1, Sia-C2), 100.6 (Fuc-C1), 99.6, 76.6, 76.3, 76.0, 75.9, S7 74.4, 73.9, 72.9, 72.8, 70.2, 69.3, 69.1, 68.7, 68.3, 67.7, 63.6, 62.4, 60.6, 56.7, 52.7, 40.8 943.3553; HPLC purity: > 99.5%.
Molecular cloning
Human E-selectin cDNA encoding the native E-selectin secretion signal, the Lec-, EGF-and first two SCR domains (E-selectin*, residues 1-280) was isolated and PCR amplified from previously cells (Scheffler et al., 1995) . The Kozak consensus sequence was introduced to increase protein yield. E-selectin* cDNA was cloned into the pcDNA3.1(+) expression vector (Life Technologies Ltd, UK) using standard cloning procedures and sequence verified.
Stably transfected CHO-K1 cells (ATCC-No. CCL-61) were generated using FuGENE ® HD Transfection Reagent (Roche Applied Science, Switzerland), G418 treatment, and subsequent clone selection. Single clones were screened for optimal protein expression. The CHO-K1 cells were cultivated as monolayer in Ham's Nutrient Mixture F-12 medium supplemented with 2 mM L-glutamine (Invitrogen, Lucerne, Switzerland), 5-10% (v/v) fetal calf serum (Invitrogen, Lucerne, Switzerland), 100 U/mL penicillin, and 100 µg/mL streptomycin. Once confluent, the transfected CHO-K1 cells were treated with culture medium containing 1 µM kifunensine (Cayman Chemical, MI) for 2 days. The medium was discarded and replaced by culture medium containing 5 µM kifunensine. Conditioned culture medium was collected weekly.
The following primers were used for amplification of E-selectin* cDNA:
SELE_koz_fw with EcoRI restriction site and Kozak consensus sequence 5'-GCGAATTCGCCGCCACCATGGGAATTGCTTCACAGTTTCTCTCAG-3' SELE_SCR2_rv with two stop codons and an EcoRV restriction site 5'-GCGATATCCTATTAAGCTTTACACGTTGGCTTCTC-3'
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Protein purification
A purification column with the functional anti-E-selectin antibody 7A9 coupled to sepharose was prepared as previously describe (Binder et al., 2012) . 
Activity assays
To verify the activity of E-selectin upon deglycosylation, the affinity towards biotinylatedpolyacrylamide (PAA) functionalized with sLe
and its isoform sLe a (Neu5Ac(α2-3)Gal(β1-3)[Fuc(α1-4)]GlcNAc) was determined similarly as previously described. (Binder et al., 2012) Briefly, fully glycosylated E-selectin expressed in absence of kifunensine, high-mannosylated E-selectin, and endoglycosidase H treated E-selectin were coated at a concentration of 0.2 µM on polystyrene dishes (Immunoplate II MaxiSorp TM 96-well microtiter plates, Nunc, Denmark) at 4 °C overnight in assay buffer (10 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1 mM CaCl 2 ) and blocked with bovine serum albumin (2% w/v in assay buffer). After washing with assay buffer, serial dilutions of sLe x -PAA or sLe a -PAA were applied, which were co-incubated with streptavidin-peroxidase (200 U/mL, Roche Applied Science, 
Fluorescence spectroscopy
Fluorescence emission spectra of E-selectin* were recorded between 300 and 450 nm (excitation at 295 nm) at 20 °C in 1.0 x 0.4 cm quartz cuvettes on a QM 7/2003 spectrofluorimeter (PTI, USA) equipped with a magnetic stirrer in 20 mM Hepes, 150 mM NaCl, pH 7.4, and a protein concentration of 0.33 µM. The binding equilibrium between glycomimetic 1 and Eselectin was followed at 20 °C in 20 mM Hepes, 150 mM NaCl, pH 7.4 via the decrease in fluorescence at 320 nm after excitation at 295 nm, at bandwidths of 1 nm and 4 nm for excitation and emission, respectively. Measurements were performed with a stirred 1x0.4 cm quartz cuvette.
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The concentration of E-selection* was kept constant at 0.5 µM and the concentration of glycomimetic was varied between zero and 240 µM. The samples were equilibrated for one minute, and their fluorescence intensities were recorded at a response time of 0.5 s and averaged over 5 s. The fluorescence intensities were plotted against the glycomimetic 1 concentration. 
Protein-ligand co-crystallization
Deglycosylated E-selectin* was co-crystallized with sLe x -OTMSE or glycomimetic 1 in a sitting (Kabsch, 1993) .
Structure determination and refinement
The structure of E-selectin*/1 was determined by molecular replacement using PHASER (McCoy et al., 2007) within the CCP4 software package (Winn et al., 2011) with the P-selectin/PSGL-1 (PDB code 1G1S) (Somers et al., 2000) structure for the Lec-and EGF domains, human mannose-binding lectin-associated serine protease-1 (PDB code 3GOV) (Dobo et al., 2009 ) for the first SCR, and human CD55 (PDB code 1H04) (Williams et al., 2003) for the second SCR.
The E-selectin*/sLe x structure was determined with the E-selectin*/1 structure. Refinement was performed with the BUSTER (Blanc et al., 2004) software and model building was performed with COOT (Emsley and Cowtan, 2004) . Restraints for the ligands were generated using PRODRG (Schuttelkopf and van Aalten, 2004) . Modeling of the TMSE protecting group of the sLe x ligand was omitted due to poor density of this flexible group. Parts of the SCR2 domain in the E-selectin*/sLe x structure were modeled on the basis of the E-selectin*/1 structure due to weak density. In the E-selectin*/sLe x structure, 15 residues are within the allowed Ramachandran region (2.7%) and 11 are outliers (2.0%). In the E-selectin*/1 structure, 14 residues are within the allowed region (2.9%) and 7 are outliers (1.4%). Data collection and refinement statistics are listed in Table S1 . Root-mean-square deviations (rmsd) for the Lec-and EGF domains were calculated with the DALI server (Holm et al., 2008) . Figures were generated with the Visual Molecular Dynamics (VMD) software (Humphrey et al., 1996) . Figure S4 Omit map of the E-selectin ligand binding site (A), the bridging region (B) and the pivot region (C) based on E-selectin/1 structure.
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Small angle X-ray scattering
Small-angle X-ray scattering (SAXS) measurements were conducted at the X12SA-cSAXS beamline (Swiss Light Source) with a sample to detector (Pilatus 2M) distance of 7.0 m and ten measurements of 0.5 s exposure time. Deglycosylated E-selectin* was diluted to 5 mg/mL and measured either in presence or absence of 3 mM glycomimetic 1 at eleven points along the sample capillary. Buffer samples (10 mM Tris-HCl, pH 7.4, 5 mM CaCl 2 ) alone were measured as reference. A control measurement with 3 mM glycomimetic 1 without protein showed no difference to the buffer control. Data were integrated and background subtracted with the PRIMUS software (Konarev et al., 2003) . Experimental and theoretical scattering curves were evaluated with the CRYSOL software (Svergun et al., 1995) . A model for the E-selectin* bent conformation was generated using the coordinates of the Lec-EGF domains of the apo-E-selectin (PDB code 1ESL) (Graves et al., 1994) structure combined with the coordinates of the two SCR
domains from E-selectin*/1. Data evaluation and fitting parameters are given in Table S2 . 
Molecular dynamics simulations
The Protein Preparation Wizard (Schrödinger, 2012c) was used to convert the extended and bent (PDB code 1G1T) (Somers et al., 2000) E-selectin crystal structures to all-atom protein models.
A rigid receptor grid was generated from the crystal structure 1G1T, using the OPLS 2005 force field (Jorgensen and Tirado-Rives, 1988; Jorgensen et al., 1996) . An initial protein-ligand complex of glycomimetic 1 docked to 1G1T was obtained through flexible docking using Glide S16 (Schrödinger, 2012b (Schrödinger, 2012c) . Each system was solvated using an orthorhombic, TIP3P water box (Jorgensen et al., 1983 ) with a minimum distance of 10 Å from the complex. Counterions (Na + and Cl -) were added to neutralize the charges and account for physiological salt concentration (0.15 M). Long-range electrostatic interactions were handled using the particle mesh Ewald summation (Darden et al., 1993) . All systems were equilibrated using the default relaxation protocol and simulated over the span of 48 ns with a time step of 2.0 fs. The SHAKE algorithm (Ryckaert et al., 1977) was applied to all heavy atom-bound hydrogens. Production runs were carried out in the Martyna-Tobias-Klein isothermal-isobaric ensemble (NPT) (Martyna et al., 1994) using the Nose-Hoover barostat to maintain a constant temperature of 300 K (Nose, 1984) . Energetic and structural data were recorded in 4.8 ps intervals. To assess the stability of the MD simulations, energetic and structural data was analyzed over the course of the entire simulation time (Table S3) . From the collected MD frames, every tenth frame (1000 frames in total) was used to calculate the average ∆G applying the molecular mechanics generalized Born surface area (MM-GB/SA) method implemented in Prime (Schrödinger, 2012d) (Table S4 ). The observed high ∆G energies as well as the high dynamic range in comparison to published experimental data (Binder et al., 2012 ) is due to limitations of the MM-GB/SA method. Protein desolvation energies, enthalpy-entropy compensation, or overestimation of electrostatic interactions as described by Guimarães et al. (Guimaraes and Cardozo, 2008; Guimaraes and Mathiowetz, 2010) are causes of energy overestimation with this method. For a more realistic representation of the binding energies, we scaled the calculated results by a factor of 13.4 based on published ITC measurements of sLe x (Binder et al., 2012) .
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Comparison of SCR domain structures and sequences Residues marked red are potential N-linked glycosylation sites. Sequence alignment was performed with the ClustalW2 server (Kim and Joo, 2010) .
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Comparison of the Lec-EGF domains of E-and P-selectin Figure S6 Sequence alignment of E-and P-selectin Lec (residues 1-120) and EGF-like (residues 121-157) domains.
Underlined residues are involved in ligand binding and/or Ca 2+ coordination in the extended conformation (taken from PDB code 1G1S for P-selectin) (Somers et al., 2000) . Residues marked red are potential N-linked glycosylation sites.
